Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
11.02
+0.08 (0.69%)
Oct 19, 2026, 10:08 AM EDT - Market open
Sutro Biopharma Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Sutro Biopharma stock has a consensus rating of "Strong Buy" and an average price target of $47.23. The average 1-year stock price forecast is 328.78% higher than the current stock price, while the lowest is $10 (-9.21%) and the highest is $61 (+453.79%).
Price Target: $47.23 (+328.78%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sutro Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 10 | 10 | 10 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $56 | Buy | Maintains | $56 | +408.40% | Oct 19, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 | Buy | Reiterates | $50 | +353.93% | Oct 16, 2026 |
| Wedbush | Wedbush | Buy Maintains $60 | Buy | Maintains | $60 | +444.71% | Oct 16, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $49 | Buy | Maintains | $49 | +344.85% | Sep 30, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $48 | Buy | Maintains | $48 | +335.77% | Aug 17, 2026 |
Financial Forecast
Revenue This Year
51.55M
from 102.48M
Decreased by -49.70%
Revenue Next Year
31.59M
from 51.55M
Decreased by -38.72%
EPS This Year
-7.77
from -16.20
EPS Next Year
-6.21
from -7.77
EPS and Forward PE are based on non-GAAP adjusted numbers.